Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$147M |
| 2 |
NVIDIA
NVDA
|
+$129M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$124M |
| 4 |
SPR
Spirit AeroSystems
SPR
|
+$109M |
| 5 |
INFN
Infinera Corporation Common Stock
INFN
|
+$98.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$97.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$93.9M |
| 3 |
UnitedHealth
UNH
|
+$68.8M |
| 4 |
Salesforce
CRM
|
+$57M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$56.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.46% |
| 2 | Financials | 3.89% |
| 3 | Industrials | 3.8% |
| 4 | Consumer Discretionary | 3.36% |
| 5 | Healthcare | 3.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SFIX
2601
Stitch Fix
SFIX
$444M
| $77.2K | ﹤0.01% |
+27,392
| New | +$107K |
|
|
UNIT
2602
Uniti Group
UNIT
$2.4B
| $76K | ﹤0.01% |
13,476
-375,154
| -97% | -$1.6M |
|
2603
NIO
NIO
$11.4B
| $74.3K | ﹤0.01% |
11,122
-2,545
| -19% | -$11.7K |
|
2604
Nektar Therapeutics
NKTR
$2.52B
| $74.2K | ﹤0.01% |
3,806
| – | – |
|
2605
DocGo
DCGO
$41.8M
| $74.1K | ﹤0.01% |
22,329
| – | – |
|
2606
CALL
Cemex
CX
$16B
| $73.2K | ﹤0.01% |
+12,000
| New | +$75.3K |
|
2607
Vanda Pharmaceuticals
VNDA
$320M
| $72.4K | ﹤0.01% |
+15,438
| New | +$82.8K |
|
|
GAN
2608
DELISTED
GAN Ltd
GAN
| $71.6K | ﹤0.01% |
40,436
| – | – |
|
2609
Precigen
PGEN
$2.54B
| $67.7K | ﹤0.01% |
71,464
| – | – |
|
2610
Seer Inc
SEER
$114M
| $65.5K | ﹤0.01% |
33,255
-6,528
| -16% | -$11.4K |
|
2611
Senseonics Holdings Inc
SENS
$500M
| $61K | ﹤0.01% |
8,719
| – | – |
|
2612
IAMGOLD
IAG
$12.2B
| $60.8K | ﹤0.01% |
11,627
-13,602
| -54% | -$62.8K |
|
|
ACCD
2613
DELISTED
Accolade Inc
ACCD
| $59K | ﹤0.01% |
+15,326
| New | +$60K |
|
2614
Caribou Biosciences
CRBU
$180M
| $58.9K | ﹤0.01% |
+30,073
| New | +$61.6K |
|
2615
Seres Therapeutics
MCRB
$45.3M
| $58.6K | ﹤0.01% |
3,099
| – | – |
|
2616
Wheels Up
UP
$180M
| $50K | ﹤0.01% |
1,034
+257
| +33% | +$12.5K |
|
2617
Gossamer Bio
GOSS
$73.1M
| $45.8K | ﹤0.01% |
46,464
| – | – |
|
|
VTYX
2618
DELISTED
Ventyx Biosciences
VTYX
| $44.4K | ﹤0.01% |
20,355
-7,778
| -28% | -$17.9K |
|
|
KLRS
2619
Kalaris Therapeutics
KLRS
$98.3M
| $40.1K | ﹤0.01% |
2,157
| – | – |
|
|
CMBM
2620
DELISTED
Cambium Networks
CMBM
| $39K | ﹤0.01% |
21,307
| – | – |
|
|
AERT
2621
Aeries Technology
AERT
$40.2M
| $38.2K | ﹤0.01% |
2,078
| – | – |
|
2622
Aclaris Therapeutics
ACRS
$936M
| $38.2K | ﹤0.01% |
33,183
| – | – |
|
|
AILE
2623
DELISTED
iLearningEngines, Inc. Common Stock
AILE
| $35.1K | ﹤0.01% |
+21,031
| New | +$107K |
|
2624
Stem
STEM
$54.5M
| $31.9K | ﹤0.01% |
4,580
| – | – |
|
|
TVRD
2625
Tvardi Therapeutics
TVRD
$24.9M
| $28.7K | ﹤0.01% |
2,587
| – | – |
|
Similar funds
Paul Tudor Jones's Q3 2024 Portfolio in Review
As of Q3 2024, Paul Tudor Jones held 3,231 positions worth $27.5B, up 41% from $19.5B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Paul Tudor Jones deployed $6.72B of net new capital in Q3 2024, opening 973 new positions and adding to 833 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 686,581 shares worth $152M.
By sector, the portfolio is most concentrated in Technology at 6.5% of assets, down from 8.7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Apple, an estimated $97.9M trimmed.
- Paul Tudor Jones's largest Q3 2024 buy was iShares Russell 2000 ETF: 686,581 shares worth $152M.
- Paul Tudor Jones added most to NVIDIA in Q3 2024, an estimated $129M increase.
- Paul Tudor Jones's biggest Q3 2024 reduction was Apple, cutting an estimated $97.9M.
- Paul Tudor Jones fully exited Bristol-Myers Squibb in Q3 2024, selling an estimated $93.9M.
- Paul Tudor Jones's ten largest holdings make up 47% of its $27.5B portfolio in Q3 2024.
- Paul Tudor Jones opened 973 new positions and closed 594 in Q3 2024.
- Paul Tudor Jones's portfolio value rose 41% quarter-over-quarter to $27.5B.
Based on Tudor Investment Corp's 13F filing for Q3 2024, filed 14 Nov 2024.